Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2019 | 04-2019 | 01-2019 | 10-2018 | 07-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,338 | N/A | -12,290 | -8,334 | -5,030 |
| Depreciation Amortization | 156 | N/A | 256 | 153 | 50 |
| Accounts payable and accrued liabilities | 392 | N/A | 1,748 | 2,088 | 1,126 |
| Other Working Capital | -5,593 | N/A | -15,920 | -8,366 | -1,585 |
| Other Operating Activity | 1,108 | 0 | 352 | -539 | -773 |
| Operating Cash Flow | $-11,275 | $N/A | $-25,854 | $-14,998 | $-6,212 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -98 | N/A | -806 | -786 | -565 |
| Purchase Of Investment | -19,646 | N/A | -55,419 | N/A | 0 |
| Sale Of Investment | 18,214 | N/A | 850 | N/A | N/A |
| Investing Cash Flow | $-1,530 | $N/A | $-55,375 | $-786 | $-565 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -54 | N/A | -155 | -104 | -52 |
| Common Stock Issued | 11,454 | N/A | 87,943 | 87,836 | 5,000 |
| Financing Cash Flow | $11,400 | $N/A | $87,788 | $87,732 | $4,948 |
| Exchange Rate Effect | -494 | N/A | -1,269 | -1,887 | -1,156 |
| Beginning Cash Position | 32,006 | N/A | 51,055 | 51,055 | 51,055 |
| End Cash Position | 30,107 | N/A | 56,345 | 121,116 | 48,070 |
| Net Cash Flow | $-1,899 | $N/A | $5,290 | $70,061 | $-2,985 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,275 | N/A | -25,854 | -14,998 | -6,212 |
| Capital Expenditure | -98 | N/A | -806 | -786 | -565 |
| Free Cash Flow | -11,373 | 0 | -26,660 | -15,784 | -6,777 |